1. Home
  2. Press release
Apr, 05 2019 10:45 JST

Source: Eisai

Eisai to Launch "Travelmin Support" as Series' First Quasi-Drug

Motion Sickness Solution Now Available in Convenience Stores

TOKYO, Apr, 05 2019 - (JCN Newswire) - Eisai Co., Ltd. will launch the mouth freshener Travelmin Support as the first quasi-drug of the Travelmin series which can be purchased even at convenience stores and others in Japan on Monday, April 8.

Travelmin Support is a quasi-drug that contains plant derived daylily extract as its main ingredient to help with motion sickness and discomfort. As a drop-type product, it is easy for children to take, and it has a refreshing cider flavor. Each drop is individually wrapped for convenience, is easy to carry around, and can be taken by both adults and children five of age and older.

After hearing the voices of many consumers who had difficulties because they forgot to purchase motion sickness medicine and were unable to obtain any during their travels, Eisai decided to launch Travelmin Support as a quasi-drug that can be purchased even at convenience stores and others.

The Travelmin series is widely familiar in Japan as a national brand of motion sickness medicines. In addition to Travelmin, which was introduced in 1952, Eisai has launched the drop-type product Travelmin Churop (class 2 pharmaceutical product) which can be taken even after becoming sick, Travelmin R (class 2 pharmaceutical product) which contains ingredients that comparatively cause less sleepiness, and others. With the introduction of Travelmin Support to the Travelmin lineup, Eisai will continue to contribute to people concerned about motion sickness and discomfort when traveling, as well as help consumers enjoy their travels.


About Eisai
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

Furthermore, we invest and participate in several partnership-based initiatives to improve access to medicines in developing and emerging countries.

For more information about Eisai Co., Ltd., please visit www.eisai.com


Contact:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Source: Eisai
Sectors: HealthCare

Copyright ©2019 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release

"Science Based Targets (SBT) Initiative" Approves Eisai's Greenhouse Gas Reduction Targets
May 17 2019 15:34 JST
 
Eisai to Present Data on Oncology Pipeline and Products at 55th Asco Annual Meeting
May 16 2019 07:37 JST
 
Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection in Japan
May 10 2019 12:34 JST
 
Eisai: Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401
May 10 2019 11:55 JST
 
Eisai and Allm Enter Into Capital and Business Alliance Agreement for ICT Healthcare Solutions
May 09 2019 11:33 JST
 
Eisai Commences Venture Investment Business Aimed at Accelerating Innovation in Drug Creation and Establishment of Ecosystem Platform
May 09 2019 11:06 JST
 
Eisai and UK Dementia Research Institute Jointly Launch New Post-Doctoral Programme to Accelerate Dementia Research
May 08 2019 08:37 JST
 
Eisai Buys Out Purdue Rights to End Collaboration
May 01 2019 08:09 JST
 
Eisai to Present Latest Data on Lemborexant and Perampanel at Annual American Academy of Neurology Meeting
April 24 2019 16:53 JST
 
Eisai Selected as Competitive ICT Strategy Company for 2019
April 24 2019 08:36 JST
 
More Press release >>

Latest Press Release


"Science Based Targets (SBT) Initiative" Approves Eisai's Greenhouse Gas Reduction Targets
May 17, 2019 16:34 JST

Toyota Rolls Out New Supra
May 17, 2019 15:49 JST

DOCOMO Develops Safe, Blade-free Drone Propelled with Ultrasonic Vibrations
May 17, 2019 12:08 JST

Hitachi Automotive Systems' EV Inverter Adopted for the e-tron, Audi's First Mass Production Electric Vehicle
May 17, 2019 11:40 JST

NEC Awarded Intelligent Transportation System Project in Oman
May 17, 2019 11:15 JST

Eisai to Present Data on Oncology Pipeline and Products at 55th Asco Annual Meeting
May 16, 2019 08:37 JST

Toyota: The Master Craftsmanship of the Century, Japan's Only Chauffeur-Driven Car
May 15, 2019 16:19 JST

NEC and CSC e-Governance Services Form a Strategic Alliance to Deliver Innovative Digital Services for Rural Areas in India
May 15, 2019 13:12 JST

Mitsubishi Shipbuilding Holds Christening Ceremony for Next-Generation LNG Carrier "BUSHU MARU"
May 15, 2019 12:14 JST

MHPS Receives Order for Two H-25 Gas Turbines for Major Chinese Paper Firm Lee & Man Paper Manufacturing Ltd.
May 15, 2019 11:37 JST

Mitsubishi Corporation: Production Underway at Cameron LNG
May 14, 2019 20:01 JST

Fujitsu Formulates "Design the Trusted Future by Data x AI", a Process and Framework for Creating Goal-Oriented Businesses
May 14, 2019 13:23 JST

NEC Becomes the First Japanese Company to Join the TESLA Consortium's Fight Against Cancer
May 14, 2019 10:12 JST

Fujitsu and Autonomic Collaborate to Bring Advanced Mobility Services to Global Automakers
May 14, 2019 09:44 JST

NEC: Grupo Gtd Goes Live With Netcracker's Full-Stack BSS/OSS Suite for B2B Transformation
May 13, 2019 20:39 JST

Tanak and the Toyota Yaris WRC Conquer a New Rally in Chile
May 13, 2019 12:36 JST

Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection in Japan
May 10, 2019 13:34 JST

Eisai: Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401
May 10, 2019 12:55 JST

Fujitsu Develops Automatic Labeling Technology to Accelerate AI Use of Time-Series Data
May 10, 2019 11:21 JST

Babson College and the Toyota Mobility Foundation Team Up to Accelerate the Future of Mobility
May 10, 2019 10:08 JST
 More Latest Release >>